Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
This map shows the geographic impact of Pierre Zachée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Zachée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Zachée more than expected).
This network shows the impact of papers produced by Pierre Zachée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Zachée. The network helps show where Pierre Zachée may publish in the future.
Co-authorship network of co-authors of Pierre Zachée
This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Zachée.
A scholar is included among the top collaborators of Pierre Zachée based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Pierre Zachée. Pierre Zachée is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Knoops, L., Gregor Verhoef, Z. N. Berneman, et al.. (2016). Real-world data from 54 Belgian patients from the ponatinib named patient programme (NPP). Ghent University Academic Bibliography (Ghent University).1 indexed citations
Hoof, Ambro van, Daan Dierickx, Virginie De Wilde, et al.. (2013). Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS).. Open Repository and Bibliography (University of Liège). 4(3). 90–101.
Noens, Lucien, G. Verhoef, Pierre Zachée, et al.. (2008). NONADHERENCE WITH IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA IS A FUNCTION OF DISEASE, HEALTH, KNOWLEDGE, AND SOCIAL FACTORS - RESULTS FROM THE ADAGIO STUDY. Ghent University Academic Bibliography (Ghent University). 93. 223–223.3 indexed citations
10.
Vandenberghe, Peter, H Demuynck, Gregor Verhoef, et al.. (1998). Intensive non-myeloablative chemotherapy can induce GvHD and complete remission in patients with AML/MDS relapsing after allo-BMT. British Journal of Haematology. 102(1). 210–210.1 indexed citations
11.
Delannoy, André, Hanneke C. Kluin‐Nelemans, MA Boogaerts, et al.. (1997). Randomized study on hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia. Blood. 91(8). 2713–2721.42 indexed citations
12.
Maertens, J., H Demuynck, Gregor Verhoef, et al.. (1996). Granulocyte-macrophage colony-stimulating factor (GM-CSF) fails to improve outcome in invasive fungal infections in neutropenic cancer patients. Blood. 88(10). 3274–3274.1 indexed citations
13.
Demuynck, H, G. Verhoef, Pierre Zachée, et al.. (1996). Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors.. PubMed. 17(5). 745–51.31 indexed citations
14.
Demuynck, H, Gregor Verhoef, Johan Maertens, et al.. (1996). Intensive chemotherapy followed by autologous progenitor cell transplantation may lead to prolonged hematological and molecular remission in chronic lymphocytic leukemia (CLL). Blood. 88(10). 488–488.1 indexed citations
15.
Kluin‐Nelemans, Hanneke C., André Delannoy, Marc Boogaerts, et al.. (1995). CML treated by low dose interferon alfa-2B vs hydroxyurea alone: interim report of a multicenter randomized trial. Blood. 86.1 indexed citations
16.
Malbrain, Manu L. N. G., et al.. (1994). Acute renal failure due to bilateral lymphomatous infiltrates. Primary extranodal non-Hodgkin's lymphoma (p-EN-NHL) of the kidneys: does it really exist?. PubMed. 42(3). 163–9.62 indexed citations
Paulus, G., et al.. (1980). Nephrotoxicity of Gentamicin in the Human-kidney. Kidney International. 18(1). 136–136.6 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.